BTI
GSK icon

Blue Trust Inc’s GSK GSK Stock Holding History

Blue Trust Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
5,179
-80
-2% -$4.23K ﹤0.01% 688
2026
Q1 		$290K Sell
5,259
-15
-0.3% -$813 ﹤0.01% 659
2025
Q4 		$259K Buy
5,274
+1,534
+41% +$71.5K ﹤0.01% 702
2025
Q3 		$161K Buy
3,740
+120
+3% +$4.69K ﹤0.01% 882
2025
Q2 		$139K Sell
3,620
-2,022
-36% -$77.3K ﹤0.01% 905
2025
Q1 		$219K Sell
5,642
-328
-5% -$12K ﹤0.01% 673
2024
Q4 		$202K Sell
5,970
-4,750
-44% -$171K ﹤0.01% 655
2024
Q3 		$413K Buy
10,720
+8,256
+335% +$338K 0.01% 543
2024
Q2 		$106K Buy
2,464
+1,546
+168% +$65K ﹤0.01% 954
2024
Q1 		$39.4K Sell
918
-421
-31% -$17.4K ﹤0.01% 995
2023
Q4 		$48K Sell
1,339
-1,437
-52% -$51.6K ﹤0.01% 957
2023
Q3 		$99K Buy
2,776
+191
+7% +$6.78K ﹤0.01% 622
2023
Q2 		$92K Sell
2,585
-1,906
-42% -$68.4K ﹤0.01% 526
2023
Q1 		$158K Buy
4,491
+1,471
+49% +$51.5K ﹤0.01% 622
2022
Q4 		$89K Sell
3,020
-182
-6% -$6.06K ﹤0.01% 707
2022
Q3 		$139K Buy
3,202
+2,280
+247% +$86.4K ﹤0.01% 423
2022
Q2 		$50K Buy
+922
New +$50.9K ﹤0.01% 681

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Blue Trust Inc's GSK Position: Q2 2026 in Review

Blue Trust Inc reduced its GSK (GSK) stake by 1.5% in Q2 2026, selling an estimated $4.23K and leaving 5,179 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #688.

Blue Trust Inc first reported a position in GSK in Q2 2022 and has held it in 17 quarters since. The position peaked at $413K in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Blue Trust Inc held 5,179 shares of GSK worth $271K as of Q2 2026.
  • Blue Trust Inc sold 80 GSK shares in Q2 2026, an estimated $4.23K.
  • GSK made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #688 holding.
  • Blue Trust Inc first reported a position in GSK in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's GSK position peaked at $413K in Q3 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.